Cellcolabs secured $12 million in primary funding from Titian Capital in Dubai
19 October 2025
19 October 2025
Total investments received (USD): 32.09m
Round value (USD): 12m
Round investors:
Titian Capital
Company: Cellcolabs
Industry:
Biotech
Health services
Related deals
One-Carbon Therapeutics raises SEK 153 million from new and existing investors in Sweden
Investments
05 November 2025
Pixelgen in a €12.5M quity financing deal with European Innovation Council
Investments
05 June 2025
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain
United Kingdom